ticlopidine has been researched along with Alveolitis, Fibrosing in 3 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A comparative clinical study examined the preventive effect of ticlopidine hydrochloride (hereinafter referred to as ticlopidine, anti-platelet drug) on Peplomycin sulfate (hereinafter referred to as Peplomycin) pulmonary fibrosis." | 7.68 | [Preventive effect of ticlopidine on peplomycin pulmonary fibrosis]. ( Fukuda, H; Negishi, T; Oowada, F; Saito, H; Saito, T; Tari, K; Tsujii, T; Yamada, T; Yonese, J; Yoshida, K, 1990) |
| "A comparative clinical study examined the preventive effect of ticlopidine hydrochloride (hereinafter referred to as ticlopidine, anti-platelet drug) on Peplomycin sulfate (hereinafter referred to as Peplomycin) pulmonary fibrosis." | 3.68 | [Preventive effect of ticlopidine on peplomycin pulmonary fibrosis]. ( Fukuda, H; Negishi, T; Oowada, F; Saito, H; Saito, T; Tari, K; Tsujii, T; Yamada, T; Yonese, J; Yoshida, K, 1990) |
| " Combination therapy of anti-platelet aggregating agents such as phthalazinol, dipyridamole, ticlopidine and indomethacin suppressed these toxic changes." | 1.28 | [Effects of anti-platelet aggregating agents on peplomycin induced pulmonary toxicity in mice]. ( Ekimoto, H; Ito, J; Okada, M; Takahashi, K, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasil'ev, SN | 1 |
| Stepanian, IE | 1 |
| Kaminskaia, GO | 1 |
| Serebrianaia, BA | 1 |
| Shmelev, EI | 1 |
| Tari, K | 1 |
| Tsujii, T | 1 |
| Yonese, J | 1 |
| Saito, T | 1 |
| Oowada, F | 1 |
| Fukuda, H | 1 |
| Negishi, T | 1 |
| Yamada, T | 1 |
| Saito, H | 1 |
| Yoshida, K | 1 |
| Okada, M | 1 |
| Ekimoto, H | 1 |
| Ito, J | 1 |
| Takahashi, K | 1 |
3 other studies available for ticlopidine and Alveolitis, Fibrosing
| Article | Year |
|---|---|
[The hemostatic system and correction of its impairments, by using the disaggregatory agent ticlopidine and low-molecular-weight heparin in patients with idiopathic fibrosing alveolitis].
Topics: Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemodynamics; Heparin, Low-Molecular-Weight; | 2005 |
[Preventive effect of ticlopidine on peplomycin pulmonary fibrosis].
Topics: Bleomycin; Humans; Infusion Pumps; Peplomycin; Pulmonary Fibrosis; Ticlopidine; Urologic Neoplasms | 1990 |
[Effects of anti-platelet aggregating agents on peplomycin induced pulmonary toxicity in mice].
Topics: Animals; Bleomycin; Lung Diseases; Male; Mice; Mice, Inbred ICR; Peplomycin; Platelet Aggregation In | 1989 |